Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

NCT06571591 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM

Interventions

DRUG: CT-L03 Group 1
DRUG: CT-L03 Group 2
DRUG: Placebo
DRUG: Empagliflozin
DRUG: Metformin

Sponsor

Celltrion